Regard, founded in 2016 by Eli Ben-Joseph and Nate Wilson, reviews a patient's full electronic health record chart, combining it with physician-patient conversation data, to surface diagnoses and documentation gaps that get buried in complex cases, conditions like malnutrition, sepsis risk, or undiagnosed hypertension a busy clinician might not catch.
That full-chart review approach, rather than documentation from a single conversation alone, closed a $61 million Series B led by Oak HC/FT in July 2024, with participation from Cedars-Sinai Health Ventures, bringing total funding past $100 million as the company continues investing in its own research-focused language models.
Enterprise pricing is quote-based around health system size and deployment scope, requiring a direct sales conversation rather than published self-serve rates. For a health system that wants a clinical intelligence layer surfacing diagnoses and documentation gaps buried across a patient's full chart, Regard's full-record review approach addresses that directly.
